Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

This study has been completed.
Information provided by:
Taiwan Otsuka Pharm. Co., Ltd Identifier:
First received: January 26, 2006
Last updated: May 14, 2008
Last verified: January 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2004
  Estimated Primary Completion Date: No date given